AU6201500A - Stress-responsive induction of a therapeutic agent and methods of use - Google Patents

Stress-responsive induction of a therapeutic agent and methods of use

Info

Publication number
AU6201500A
AU6201500A AU62015/00A AU6201500A AU6201500A AU 6201500 A AU6201500 A AU 6201500A AU 62015/00 A AU62015/00 A AU 62015/00A AU 6201500 A AU6201500 A AU 6201500A AU 6201500 A AU6201500 A AU 6201500A
Authority
AU
Australia
Prior art keywords
stress
methods
therapeutic agent
responsive induction
responsive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62015/00A
Inventor
Amy S. Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU6201500A publication Critical patent/AU6201500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU62015/00A 1999-06-28 2000-06-28 Stress-responsive induction of a therapeutic agent and methods of use Abandoned AU6201500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14150599P 1999-06-28 1999-06-28
US60141505 1999-06-28
PCT/US2000/017885 WO2001000791A1 (en) 1999-06-28 2000-06-28 Stress-responsive induction of a therapeutic agent and methods of use

Publications (1)

Publication Number Publication Date
AU6201500A true AU6201500A (en) 2001-01-31

Family

ID=22495982

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62015/00A Abandoned AU6201500A (en) 1999-06-28 2000-06-28 Stress-responsive induction of a therapeutic agent and methods of use

Country Status (5)

Country Link
EP (1) EP1194527A4 (en)
AU (1) AU6201500A (en)
CA (1) CA2377434A1 (en)
HK (1) HK1044568A1 (en)
WO (1) WO2001000791A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656732B1 (en) 2001-05-18 2003-12-02 Isis Pharmaceuticals, Inc. Antisense inhibition of src-c expression
US20070275011A1 (en) * 2003-09-08 2007-11-29 Terry Tamsin D Inducible Bacterial Expression System Utilising Sspa Promoter from Salmonella

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0680517T4 (en) * 1993-01-21 2005-05-02 Harvard College Method and Diagnostic Kits to Determine the Toxicity of a Compound Using Mammalian Stress Promoters

Also Published As

Publication number Publication date
HK1044568A1 (en) 2002-10-25
WO2001000791A1 (en) 2001-01-04
EP1194527A1 (en) 2002-04-10
CA2377434A1 (en) 2001-01-04
WO2001000791A9 (en) 2002-07-25
EP1194527A4 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
AU7339800A (en) Ophthalmic device and method of manufacture and use
AU9197898A (en) Resilient wrist support and therapeutic hand exerciser and method of manufacture
AU1050301A (en) Anti-arrhythmic device and a method of delivering anti-arrhythmic cardiac therapy
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU4717301A (en) Catheter assembly and method of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU715620C (en) Therapeutic methods and uses
AU3622600A (en) Metalloproteinases and methods of use therefor
AU1164601A (en) Therapeutic use and formulation
AU4848200A (en) Intravascular device and methods of manufacture and use
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU4014700A (en) Tuberculosis antigens and methods of use therefor
AU3270301A (en) Combined pde3 and pde4 inhibitor therapy for the treatment of obesity
AU3501700A (en) Human endokine alpha and methods of use
IL146465A0 (en) Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6582698A (en) Therapeutic uses of grip and grip-related molecules
AU6201500A (en) Stress-responsive induction of a therapeutic agent and methods of use
AU1490801A (en) Targeted delivery of therapeutic and diagnostic moieties
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU2001284743A1 (en) Therapeutic topical solution for skin and associated methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase